Reuters: Global Markets: Alexion shares rise after report of approach by Roche

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Alexion shares rise after report of approach by Roche Jul 30th 2013, 19:08 Tue Jul 30, 2013 3:08pm EDT (Reuters) - Shares of Alexion Pharmaceuticals Inc (ALXN.O) rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG (ROG.VX) made an informal approach to the biotech company last week about a takeover. Bloomberg, citing one unnamed person with knowledge of the matter, said that Alexion had rebuffed the approach and had retained Goldman Sachs to prepare for a possible offer. Officials at Alexion and Roche were not immediately available to comment on the report. Goldman Sachs declined to comment. Earlier this month, people familiar with the matter told Reuters that Roche was seeking financing for a potential bid for Alexion, whose market value neared $22 billion before Tuesday's share move. Alexion sells Soliris, one of the world's most expensive medicines, used to treat a progressive, life-threatening blood disorder called paroxysmal nocturnal hemoglobinuria that causes destruction of red blood cells.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions